A detailed history of Wilkins Investment Counsel Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Wilkins Investment Counsel Inc holds 16,857 shares of ABBV stock, worth $2.82 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
16,857
Holding current value
$2.82 Million
% of portfolio
0.45%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $2.69 Million - $3.07 Million
16,857 New
16,857 $3.07 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wilkins Investment Counsel Inc Portfolio

Follow Wilkins Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilkins Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wilkins Investment Counsel Inc with notifications on news.